Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Molecular Genetics and Metabolism|April 17, 2019
Pathogenesis and clinical features of the acute hepatic porphyrias (AHPs)Herbert L Bonkovsky, Natalia Dixon, Sean Rudnick
Hepatology Communications|February 16, 2019
Acute Hepatic Porphyrias: Review and Recent ProgressBruce Wang, Sean Rudnick, Brent Cengia, et al.
Molecular Genetics and Metabolism Reports|February 9, 2019
Benefits of prophylactic heme therapy in severe acute intermittent porphyriaPradeep Yarra, Denise Faust, Mary Bennett, et al.
Annals of Hepatology|February 25, 2017
A Randomized Controlled Trial of Procedural Techniques for Large Volume ParacentesisAmy Shriver, Sean Rudnick, Nicolas Intagliata, et al.
Drug Design, Development and Therapy|June 23, 2022
Spotlight on Givosiran as a Treatment Option for Adults with Acute Hepatic Porphyria: Design, Development, and Place in TherapyChaudry Nasir Majeed, Christopher D Ma, Ted Xiao, et al.
The American Journal of Gastroenterology|June 13, 2023
When Is Suspected Drug-Induced Liver Injury (DILI) Not DILI? An Analysis of Unlikely Cases From the Drug-Induced Liver Injury NetworkA Sidney Barritt, Huiman Barnhart, Jiezhun Gu, et al.
AME Case Reports|August 2, 2024
Novel UROD mutation for porphyria cutanea tarda, type 2: a case reportStephen Soufleris, Michelle Moore, John D Phillips, et al.
Molecular Genetics and Metabolism|June 3, 2019
Pilot study of mitochondrial bioenergetics in subjects with acute porphyriasNatalia Dixon, Ting Li, Brandon Marion, et al.
Hepatology Communications|February 19, 2025
Liver involvement in a large cohort of patients with erythropoietic protoporphyria or X-linked protoporphyriaCynthia Levy, Hetanshi Naik, Jessica Overbey, et al.
Pageof 1